Soluble interleukin-2 receptor retains prognostic value in...

Annals of Oncology 2008 / 10 Vol. 20; Iss. 3

Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy

Ennishi, D., Yokoyama, M., Terui, Y., Asai, H., Sakajiri, S., Mishima, Y., Takahashi, S., Komatsu, H., Ikeda, K., Takeuchi, K., Tanimoto, M., Hatake, K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdn677
Date:
October, 2008
File:
PDF, 110 KB
english, 2008
Conversion to is in progress
Conversion to is failed